Amphetamines analysis in wastewaters - method performance of solid phase extraction - higher performance liquid chromatography mass spectrometry techniques (SPE-HPLC MS/MS) by Ajao, Usman L. & Mustapha, Aliru Olajide
EXCLI Journal 2011;10:140-148 – ISSN 1611-2156 
Received: July 21, 2011, accepted: August 17, 2011, published: August 19, 2011 
 
140 
Original article: 
 
AMPHETAMINES ANALYSIS IN WASTEWATERS -  
METHOD PERFORMANCE OF SOLID PHASE EXTRACTION - 
HIGHER PERFORMANCE LIQUID CHROMATOGRAPHY MASS 
SPECTROMETRY TECHNIQUES (SPE-HPLC MS/MS) 
 
Aliru Olajide Mustapha
1*
, Usman L Ajao
2 
 
1
 School of Science and Technology, Erasmus Darwin Building ERD 200, Nottingham Trent 
University, Clifton Lane, NG11 8NS, UK 
2
 Department of Chemistry, University of Ilorin, P.M.B. 1515, Ilorin, Kwara State, Nigeria 
*
 Corresponding author: ammbarsaliu@yahoo.com 
 
ABSTRACT 
 
Recently, many articles have reported different levels and distribution of amphetamine hither-
to detected in biological fluids now appreciably found in aquatic environment at ng/L levels. 
Identification and measurement of amphetamine and its metabolites in surface and sewage 
waters using higher performance liquid chromatographic methodologies in the literatures now 
on current trend have provided information that are of scientific interest and effectively re-
placed immunological methods which only suggest the presence of these substances. Active 
research on both distribution and impacts of this important drug of abuse and related metabo-
lites in the wastewaters are on-going. 
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INTRODUCTION 
The survey of reported liquid chroma-
tography tandem mass spectrometry 
(HPLC-MS/MS) methods from literatures 
for the determination of amphetamine and 
human metabolites in waters (van Nuijs et 
al. 2009a; Zuccato et al., 2005, 2008; Cas-
tiglioni et al., 2006; Hearn et al., 1991; 
Bones et al., 2007) is discussed in this pa-
per. The higher performance liquid chroma-
tography-mass spectrometry (HPLC-MS) or 
with tandem mass spectrometry (HPLC-
MS/MS) were becoming popular in their 
separation and detection capabilities, as 
they appear very rapid, sensitive and selec-
tive method at ng/mL concentration levels. 
The concentrations of amphetamine and its 
metabolites in aqueous media using HPLC-
MS or HPLC-MS/MS appeared to have 
largely replaced GC-MS in the analysis of 
illicit substances particularly in aqueous 
media. The extraction volumes, mobile 
phases, detectors (interfaces) and acquisi-
tion modes used by different scientists to 
provide sensitivity and selectivity are 
shown. The separation procedures rely on 
the principles of reversed-phase columns 
with different solvent gradients depending 
on applications. Tabulated are limits of 
quantifications depending on matrices for 
quantification and confirmation of drugs. 
Recently, variations over convectional 
HPLC-MS method have appeared in the 
literature with the name: Ultra-performance 
liquid chromatography (UPLC-MS/MS) is 
unique for its short columns packed with 
small particles sizes and stability at pH 
range (Bijlsma et al., 2009; Wood et al., 
2005; Huerta-Fontela et al., 2008a; Boleda 
et al., 2007; Kasprzyk-Hordern et al., 2007, 
2008). With the development of this rela-
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tively new technology, a shorter analysis 
times as well as gain in separation, efficien-
cy, resolution and sensitivity have been re-
ported. To minimize the effects of ion sup-
pression on the analytical signal, a relative-
ly new HILIC (Hydrophilic interaction 
chromatography) technique was also car-
ried out in some experiments. Since ana-
lytes were better retained on HILIC col-
umn, unaffected by ion suppression and a 
reduction in analytical signal was mini-
mised, the possibilities of using HILIC ap-
proach in the quantitative determination of 
polar compounds such as amphetamine and 
its metabolites was apparently justified (van 
Nuijs et al., 2009b; Gheorghe et al., 2008). 
The use of MS/MS with triple quadrupole 
(QqQ) analyzers with electrospray ioniza-
tion (ESI
+
) were mostly used in selected 
reaction monitoring mode (SRM) to minim-
ize the matrix interferences. The choices of 
ionization in ESI positive-ion mode were to 
have achieved ionizations and simultaneous 
determinations of analytes.  
To assess inherent selectivity and pecu-
liar reservations of each method based on 
the compound and its metabolites wide 
range of polarities and extraction challenges 
from different aquatic (wastewater, sedi-
ment, sludge) matrices, this paper therefore 
hopes to review the high quality work pub-
lished in the literature on amphetamine and 
its metabolites using HPLC methods to 
maximise future application needs. 
 
AMPHETAMINE AND 
METABOLITES 
Among the drugs classified as amphe-
tamines are amphetamines (AM), meth-
amphetamines (MA, “speed”) and methyle-
nedioxymethamphetamine (MDMA, “ecs-
tasy or Adam”). They are usually taken 
orally but can be snorted, smoked or in-
jected. They are addictive stimulant drugs 
that affect the central nervous system 
among other risks of dependence and abuse. 
Other designer drugs are methylenedioxy-
amphetamine (MDE, “eve”) and 3,4-methy-
lenedioxyamphetamine (MDA, “love pills”) 
(EMCDDA, 2007). 
The major metabolic pathway involves 
deamination of cytochrome P450 to para- 
hydroxyl amphetamine and phenylacetone, 
this later compound is oxidised to benzoic 
acid and excreted as glucuronide or glycine 
(hippuric acid) conjugates. Smaller amounts 
of amphetamine are also converted to nor-
epheridine by oxidation. Although most en-
zymes involved in amphetamine metabol-
ism have not been clearly defined, CYP2D6 
is known to be involved with the formation 
of 4-hydroxylamphetamine. 
Since CYP2D6 is genetically polymor-
phic, population variation in amphetamine 
metabolism are a possibility (Ensslin et al., 
1996). Figure 1 shows that MDMA gene-
rates free and conjugated MDA, which is a 
common metabolite of MDE and MDMA. 
Other metabolites from MDMA are 4-hy-
droxy-3-methoxymethamphetamine, HMMA 
and 4-hydroxy-3-methoxyamphetamine, 
HMA (Kloss et al., 1984). With normal 
urine pHs, approximately half of an admi-
nistered dose of amphetamine is excreted as 
derivatives of alpha-hydroxylamphetamine 
and another approximately 30-40 % of the 
dose can be excreted as parent ampheta-
mine, this is because the urinary recovery 
of amphetamine is depending on pH and 
urine flow rate (Dollery, 1991). 
 
 
 
Figure 1: Main metabolites of 3,4-methylene-
dioxymethamphetamine (MDMA) in urine (Kloss 
et al., 11984) 
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HPLC-MS/MS METHODOLOGIES 
Emerging contaminants of various bio-
logical active compounds, pharmaceuticals, 
personal care products, herbicides and anti-
biotics are present in complex and varying 
compositions in wastewaters and sewages. 
The procedures employed by different au-
thors and published in the literatures in the 
past decade which include sample pre-
concentration as an important step to the 
determination of amphetamine and related 
metabolites, followed by higher perfor-
mance liquid chromatographic-tandem 
mass spectrometry separation and detection 
have been reviewed and summarised in Ta-
ble 1 (at the end of this paper). 
 
Sample pre-concentration 
Improved sample clean-ups, pre-treat-
ment, chromatographic separation, centri-
fugation, filtration, alternative ionization 
and the use of deuterated compounds as 
surrogate standards have been employed by 
authors (Kloss et al., 1984; van Viet et al., 
1990; Ellenhorn and Barceloux 1988; Kol-
brich et al., 2006; Cone, 1995; Hilton and 
Thomas, 2003; Marais and Laurens, 2009) 
to reduce the signal effects  thereby correct-
ing the matrix influences. To avoid sample 
degradation, dark-glass bottles with sam-
ples stored at -20 
o
C at a pH of 6 have been 
recommended (Hearn et al., 1991; Bones et 
al., 2007; Bijlsma et al., 2009; Wood et al., 
2005). Solid phase extraction using differ-
ent extraction protocols achieving different 
extraction method recoveries of 50-105 %, 
(Kloss et al., 1984); 50-65 % (Ellenhorn 
and Barceloux, 1988); 73-96 % (Hummel et 
al., 2006); 90 % (Hilton and Thomas, 
2003), and 65-106 % (Drummer et al., 
2007) respectively. When using HPLC-
MS/MS with electro spray ionization detec-
tor (ESI) as interface, the matrix effect is 
one of the major factors affecting the isola-
tion and analysis of drugs in complex ma-
trices like wastewaters and sewages (Hum-
mel et al., 2006). Co-elution of matrix subs-
tituents causes suppression or enhancement 
of signal which ultimately affects the accu-
racy and reliability of results. 
 
Amphetamine in the aqueous environment 
The major metabolites that have been so 
found and quantified are summarised in 
Table 2. However, the presence of some 
human amphetamine metabolites identified 
in biological fluids (Kloss et al., 1984; 
Cone, 1995; Ambre, 1985; Chen et al., 
2008; Zhang and Zhou, 2007; Quintana et 
al. 2005; Wylie et al., 2005; Yu et al., 2009) 
are yet to reported in the aquatic environ-
ment. 
 
Table 2: Amphetamine and metabolites 
 
Human metabolites iden-
tified in biological fluids 
 
 
Chen et al., 2008;  
Zhang and Zhou, 2007;  
Quintana et al., 2005;  
Wylie et al., 2005;  
Yu et al., 2009 
Human metabolites 
identified in the aquatic 
environment 
 
Kloss et al., 1984; 
Ellenhorn and Barce-
loux, 1988; 
Cone, 1995; 
Ambre, 1985 
 
Amphetamine detected 
Metamphetamine detected 
p-OHMA not detected 
p-OHMA-Glu not detected 
p-OHMA-Sul not detected 
MDA detected 
MDMA detected 
MDEA detected 
MBDB detected 
 
In many parts of Europe, amphetamine 
and its metabolites have been reported in 
many wastewaters, surface waters and se-
wage at nanogram and microgram concen-
tration levels with influent samples contain-
ing more of amphetamine and metabolites 
than effluents collected from sewage treat-
ment plants, STPs (Table 3). 
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Table 3: Amphetamine and metabolites concentration in wastewaters worldwide 
 
Analytes Matrix Influent  
(ng L
-1
) 
Effluent  
(ng L
-1
) 
SW  
(ng L
-1
) 
Volume References 
Amphetamines 3 Rivers, Italy - - < 0,65 N/A Zuccato et al., 2008 
 Eastern Spain 1400 110-210 - N/A Bijlsma et al., 2009 
 2 STPs, Italy 5.4-14.7 + 10.6 2.8 - 1-2 L Castiglioni et al., 2006 
 42 STPs, NE Spain 03-6880 04-2100 - N/A Huerta-Fontela  
et al., 2008 
 Barcelona, Spain 20.8-41.1 + 9.1 0.45-2.2 + 0.1 2.84 1 L Postigo et al., 2008 
 5 STPs, Spain 15 < 1.0 < 0.8 1.5 L Huerta-Fontela  
et al., 2008 
Metamphet-
amine 
5 STPs, Nebraska, 
USA 
1.3 + 0.1-1.4 3501 + 78.3 - 2.5 L Bartelt-Hunt et al., 
2009 
 Eastern Spain - < 100-540 - N/A Bijlsma et al., 2009 
 2 STPs, Italy < 500 < 1.11-3.5 + 2 - 1-2 L Castiglioni et al., 2006 
 42 STPs, NE Spain 3-277 3-90 - N/A Huerta-Fontela  
et al., 2008 
 3 STPs, USA 15 + 2-66 + 14 0.8-1.3 - N/A Jones-Lepp et al., 
2004 
 Barcelona, Spain 4.8-18.2 + 5.8 2.1-6.3 + 0.6 2.87 1 L Postigo et al., 2008 
 Murray, USA 6.0-34 03-7 - 2 L Hearn et al., 1991 
MDA 42 STPs, NE Spain 03-266 01-200 - N/A Huerta-Fontela  
et al., 2008 
 3 Rivers, Italy - - 3 + 0.3-4 N/A Zuccato et al., 2005 
 Eastern Spain 500-1400 410-680 - N/A Bijlsma et al., 2009 
 2 STPs, Italy 4.6 + 7.3-8.7 0.9 + 1.9-1.1 + 1.5 - 1-2 L Castiglioni et al. 2006 
 5 STPs, Spain 03-266 1-200 - 1.5 L Huerta-Fontela  
et al., 2008 
MDMA 3 Rivers, Italy - - 1.1-4.0 N/A Zuccato et al., 2008 
 Eastern Spain 326-2700.5 100-2100.2 - N/A Bijlsma et al., 2009 
 2 STPs, Italy 13.6 + 12.6-14.2 + 14.5 4.4 + 3.7-5.1 + 3 - N/A Castiglioni et al., 2006 
 5 STPs, Spain 91 67 3.5 1.5 L Huerta-Fontela  
et al., 2008 
 STP, Italy 2-598 2-267 - 1 L Huerta-Fontela  
et al., 2008 
 Barcelona, Spain 133-135.13 + 29.8 82.1-148.2 + 22.2 129 1 L Postigo et al., 2008 
 Murray, USA < 1.0-10.0 - - 2 L Hearn et al., 1991 
 42 STPs, NE Spain 2-598 2-267 - N/A Huerta-Fontela  
et al., 2008 
MDEA 5 STPs, Spain 27 < 2.1 - 1.5 L Huerta-Fontela  
et al., 2008 
 2 STPs, Italy 4.19-1.5 + 3.8 < 1.64 - N/A Castiglioni et al., 2006 
 STP, Italy 6-114 12 - 1 L Bijlsma et al., 2009 
 STP, Spain < 500 < 100 - N/A Huerta-Fontela  
et al., 2008 
 
 
HPLC method performances 
The survey of reported HPLC-MS/MS 
methods for the determination of ampheta-
mine and human metabolites in water with 
the extraction volumes, mobile phases, de-
tectors (interfaces) and acquisition modes 
used by different scientists to provide sensi-
tivity and selectivity is shown in Table 1.  
The application of LC-MS
2
 to the si-
multaneous analysis of a wide variety of 
illicit drugs in waste water was first re-
ported by Castiglioni et al. (2006). The 
HPLC column (XTerra MS C18, 100 x 
2.1 mm, 3.5 µm) with four separate total 
gradient elution times of 28, 32, 36 and 26 
min for amphetamines, cocainics, opiods 
and cannabinoids were reported respective-
ly. Wastewater samples (50 mL) were 
spiked with 20 ng of internal standards (co-
caine-d3, benzoylecgonine-d3, norcocaine-
d3, cocaethethylene-d8, amphetamine-d6, 
methamphetamine-d9, MDA-d5. MDMA-d5, 
MDEA-d5, morphine-d3, morphine-3β-D-
glucuronide-d3, 6-acetylmorphine-d6, me-
thadone-d3, EDDP-d3 and 11-nor9-carboxy-
Δ-THC-d3) and extracted using a standard 
Oasis MCX SPE procedure. Quantitation 
was based on the 
 
MH
+ 
peak areas of the 
analyte relative to the MH
+
 peak areas of 
the corresponding internal standards. The 
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mobile phase solvent A: acetic acid 0.05 % 
in water and solvent B: acetonitrile. But 
solvent A for cannabinoids was triethyla-
mine 0.05 % in water. ESI gave abundant 
protonated molecule ions (MH
+
) for each of 
the analytes and internal standards. Meas-
ured quantitation ranges were: 0.2-1 µg/L 
for cocaine and its metabolites, 80-200 ng/L 
for morphine, 10 ng/L for 6-acetylmor-
phine, 60-90 ng/L for methadone and its 
metabolite 2-ethylidene-1,5-dimethyl-3,3-
diphenylpyrrolidine and lower than 20 ng/L 
for amphetamines. The overall method va-
riability was ≤ 10 % for the influents, ≤ 5 % 
for effluents and recoveries in wastewater 
were ≥ 80 %. 
The use of Polar Organic Chemical In-
tegrative Samplers (POCIS) methodology 
for sampling was introduced by Bartelt-
Hunt et al. (2009), the samplers were in-
stalled in rivers upstream and downsteam of 
treated WWTP at five different sites. The 
HPLC separation was performed isocrati-
cally on a Betabasic-18 column (250 x 
2.1 mm, 5 µm, and 50 
o
C) with a mobile 
phase of methanol with 0.1 % formic acid 
in water. The electrospray ionization in pos-
itive mode (ESI
+
) by multiple reaction mon-
itoring gave the mass spectrum of the ana-
lytes. Each of the POCIS devices was re-
moved from its deployment canister, and 
the contents were transferred with 20 mL 
high-purity methanol into silane-treated 
vials, stored at -20 
o
C and compounds were 
eluted with 50 mL of high-purity methanol 
through silane-treated gas gravity flow 
chromatography columns into 120 mL eva-
poration tubes. After addition of the internal 
standards (metamphetamine-d9, 
13
C3-
caffeine, and 
13
C8-sulfamethazine), the 
eluates were evaporated to approximately 
1 mL under nitrogen and quantitatively 
transferred to autosampler for analysis. The 
estimated detection limits for most com-
pounds were less than 1 pg/µL while the 
averaged recovery was 123 ± 30 %; howev-
er, the determination of the uptake rates for 
the compounds of interest for quantitative 
analysis is the limitation of POCIS. 
Ultra-performance liquid chromatogra-
phy (UPLC-ESI-MS/MS) is a variation 
over convectional HPLC-MS
 
method. The 
ultra-fast LC-MS
2
 is unique for its short 
columns packed with small particles sizes 
and stability at pH range; with the devel-
opment of this relatively new technology, a 
shorter analysis times as well as gain in se-
paration, efficiency, resolution and sensitiv-
ity are introduced (Huerta-Fontela et al., 
2008).  
The occurrence of psychoactive drugs 
in wastewaters using the new UPLC-ESI- 
MS
2
 technique (Huerta-Fontela et al., 2008; 
Wood et al., 2005) on an Acquity BEH C18 
UPLC column, (100mm x 2.imm i.d., 
1.7 µm particle size) after enrichment by 
solid phase extraction (SPE). The optimized 
separation conditions were for solvent A: 
acetonitrile with 0.1 % formic acid; solvent 
B: 30 mM formic acid/ammonium formate 
(pH 3.5) at a flow rate of 0.5 mL/min. The 
ESI working in positive mode with acquisi-
tion in selected reaction mode (SRM) gave 
abundant protonated molecular ion of each 
compound as the precursor ion: nicotine 
(163>130; 163>117), cotinine (177>80; 
177>98), caffeine (195>138; 195>110), pa-
raxantine (181>124; >181>96), ampheta-
mine (136>119; 136>91), MDA (180>163; 
180>105), metamphetamine (150>91; 
150>119), MDMA (194>163; 194>105), 
MDEA (208>163; 208>133), ketamine 
(238>125; 238>220), cocaine (304>182; 
304>105), benzoylecgonine (290>169; 
290>150), LSD (324>223; 324>208), PCP 
(244>85; 244>159) and fentanyl (337>188; 
337>105). The LODs were lower than 1.5 
ng/L and 300 ng/L where LOQs were lower 
than 5 ng/L and 850 ng/L, respectively, 
with the recoveries ranged from 70 to 
101 %. 
At the University of Glamorgan, Sus-
tainable Environmental Research Centre, 
UK, Kasprzyk-Hordern et al. (2007) made 
use of the new, fast and sensitive method 
for the broad range of pharmaceuticals, illi-
cit drugs which include amphetamines with 
triple quadrupole tandem mass spectrome-
try with positive-ion mode (ESI
+
) was used 
for separation of up to 30 compounds on 
Acquity UPLC BEH C18 column (1.7 µm; 1 
mm x 100mm) with mobile phase A: (pH, 
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2.8) of 94.5 % of H2O, 5 % MeOH, 0.5 % 
CH3COOH and mobile phase B: (pH, 3.2) 
of 99.5 % MeOH and 0.5 % CH3COOH 
after Oasis MCX, sorbent extraction. The 
methods limits were of quantification 
ranged from 0.3 to 50 ng/L with the instru-
mental limit of quantification from 0.2 to 
10 µg/L. 
Bijlsma et al. (2009) recently reported 
use of UPLC-MS/MS method came from 
for the simultaneous determination of am-
phetamines, cocaines, cannabis and their 
metabolites in surface and waste water. Af-
ter SPE enrichment, the selected drugs were 
separated on Acquity BEH C18 UPLC col-
umn, (50 mm x 2.1 mm i.d., 1.7 µm particle 
size) with methanol (solvent A) and 5 mM 
ammonium acetate/0.1 % formic acid (sol-
vent B). The use of MS/MS with triple qua-
drupole (QqQ) analyzers with electrospray 
ionization (ESI
+
) was used in selected reac-
tion monitoring mode (SRM) to minimize 
the matrix interferences. The choice of io-
nization in ESI positive-ion mode was deli-
berate to have abundant ionization of THC-
COOH as well as simultaneous determina-
tions for all the analytes. The recoveries of 
70-120 % were reported with precision of 
≤ 20 % for all compounds. 
 
CONCLUSIONS 
HPLC-MS has been widely used as a 
good technique for highly polar, highly mo-
lecular weight and thermolabile compounds 
for the determination of amphetamine and 
its active metabolites in waters. No hydro-
lysis, no derivatization, one-step extraction 
especially with the introduction of API and 
ESI interfaces, the technique has been pop-
ular. 
The Oasis MCX was also a good choice 
because its mixed mode materials during 
loading, washing and elution steps allows 
improved selectivity towards basic analytes 
due to pH and polarity changes. The inter-
nal standard was found as valuable tool for 
standardization and quantification and has 
almost identical physicochemical properties 
like the normal drugs and their metabolites 
analogues. Like cocaine analysis and simi-
lar drugs, the Oasis HLB cartridge built of a 
hydrophilic and a lipophilic monomer and 
Oasis MCX cartridge - a mixed reversed-
phase/cation-exchange - were common car-
tridges for drug extraction with good reco-
veries. However, insufficient reference 
standards in contrast to GC-MS technique 
(which has large data bases of mass spec-
tral) has made HPLC less attractive in stu-
dies where structural confirmation is 
needed. 
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Table 1: Survey of reported HPLC-MS/MS methods for the determination of amphetamine and human metabolites in water (2000-2010) 
 
Analytes Matrix Sample preparation LC MS Method  
LOQ (ng/L) 
Reference 
  Volume 
(mL) 
Extraction Method  
Recovery (%) 
Chromatographic  
column 
Mobile phase Detector 
(interface) 
Acq. 
mode 
  
1 ALC WW 500 mL SPE  
(Strata-XC,  
200 mg) 
50-65 % HPLC: Phenomenex 
Onyx C18 (200 x 3.0 mm 
i.d.) 
NR NR NR 36-120 Bones et al., 2007 
5 ALCs WW 50 mL SPE  
(Oasis, MCX,  
60 mg) 
50-105 % HPLC:  
XterraMS C18  
(100 mm x 2.1 mm,  
3.5 µm) 
250 µL/min 
A: CH3COOH/ 
 H2O 
 B1: AcN 
A2 0.05 % TEA/H2O 
QqQ (EST
+
) MRM 300 pg/L 
wwinf
 
1 ng/L 
wweff
 
Castiglioni et al., 
2006 
1 ALC WW 250 mL SPE  
(Oasis, HLB,  
200 mg) 
36-49 % HPLC:  
Varian Pursuit XRs C18  
(100 mm x 2.0 mm,  
3 µm) 
A: de-ionized water/ 
0.5 % 
 HCOOH 
B: 82 % CH3OH/ 
 18 %/AcN/  
 0.5 % HCOOH 
 Scan 
(CID) 
0.25-5.0 Hearn et al., 1991 
5 ALCs WW 100 mL SPE  
(Oasis, HLB,  
200 mg) 
70-110 % UPLC:  
Acquity BEH C18  
(100 mm x 2.1 mm,  
1.7 µm) 
A: AcN/0.1 % 
 HCOOH 
B: 30 mM 
HCOOH/NH4HCO2  
(pH 3.5) 
 QqQ 
(EST
+
) 
5 and 850 Huerta-Fontela et 
al., 2008 
1 ALC SW 100 mL SPE  
(Oasis, MCX,  
60 mg) 
65-106 % UPLC:  
Acquity BEH C18  
(1.7 µm,  
1 mm x 100 mm) 
A: 94.5 % H2O 
5 % MeOH,  
5 % CH3COOH  
(pH 2.8)  
B: 99.5 % MeOH +  
0.5 % CH3COOH  
(pH 3.2) 
QqQ (EST
+
) MRM 0.3-50 Kasprzyk-Hordern et 
al. 2007 
 
Acq. mode - Acquisition mode- SRM, Selected reaction monitoring; CID, Collision-induced dissociation. Detector and interface used – QqQ, Triple quadrupole; 
ITMS, Ion Trap mass spectrometry, ESI, Electrospray ionization. MeOH – Methanol; TEA, Triethylamine; NH4HCO2, Ammonium acetate; AcN, Acetonitrile, H2O, 
Water.  WW, Wastewater;  SW, Surface water; WW
inff
, Waste water influent;  WW
eff
, Waste water effluent. RPLC, Reversed-phase liquid chromatography; 
UPLC, Ultra-performance liquid chromatography; HILIC, Hydrophilic interaction chromatography. ALCs: amphetamine-like compounds 
 
